Jan 14, 2025 · The Big 3 PBMs netted such significant revenues all while patient, employer, and other health care plan sponsor payments for drugs steadily increased annually, according to …

The Federal Trade Commission today published an interim report on the prescription drug middleman industry that underscores the impact pharmacy benefit managers (PBMs) have on …

This report confirms that the Big 3 PBMs impose significantmarkups on a wide array of specialty generic drugs. The FTC issues this staffreport in connection with our ongoing study of the …

Jan 14, 2025 · The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying the major industry middlemen generate …

Jan 19, 2025 · In a rebuttal to the FTC report issued in the summer, the PCMA criticized the Commission’s analysis for “falling far short of being a definitive, fact-based assessment of …

Jul 11, 2024 · The FTC blasted pharmacy benefit managers, accusing them of raising patients’ costs and driving pharmacies out of business. The FTC is planning to sue the 3 largest PBMs.

Jul 9, 2024 · In the report, the FTC highlights how unchecked consolidation has created a market where the six largest PBMs control almost 95% of the prescriptions filed in the U.S., allowing …

Jan 15, 2025 · The Federal Trade Commission (FTC) released its second interim staff report “Specialty Generic Drugs a Growing Profit Center for Vertically Integrated Pharmacy Benefit …

Jul 11, 2024 · An interim report released July 9 by the FTC highlights the “enormous power” third party players, known as pharmacy benefit managers (PBMs), have over prescription drug …

Jan 22, 2025 · The FTC’s First Interim Report found that pharmacies affiliated with the three largest PBMs in the United States received 68 percent of all revenue for dispensing specialty …